Bipolar II vs. Depression: Why Getting This Right Changes Everything 

You’ve been taking antidepressants for years, but the depression keeps coming back worse. Your doctor adds another medication, then another. What nobody mentioned is that 40% of people diagnosed with depression actually have bipolar disorder, and those antidepressants might be making things worse, not better. This guide explains why getting the right bipolar diagnosis and medication regimen isn’t just important, it changes everything.

Let me start with what most psychiatrists won’t tell you up front. Getting bipolar medication right is incredibly complex, and the margin for error is huge. A medication that stabilizes one person’s mood might send another into mania. The drug that finally lifts your depression might also make you gain 40 pounds or require monthly blood tests.

This isn’t about finding a single pill that fixes everything. It’s about understanding why precision matters, what happens when you get it wrong, and how to work with your psychiatrist to find a regimen that actually works for your specific type of bipolar disorder.

The Misdiagnosis Crisis: Why 40% Get It Wrong

Bipolar disorder misdiagnosis occurs when patients presenting with depressive symptoms are incorrectly diagnosed with unipolar major depression rather than bipolar disorder, leading to treatment with antidepressants alone. This misdiagnosis affects 40-69% of bipolar patients and results in delayed appropriate treatment, potential antidepressant-induced mania, and years of ineffective medication trials before the correct diagnosis emerges.

Here’s a statistic that should concern every person dealing with mood disorders. Studies show that 40% to 69% of people with bipolar disorder are initially misdiagnosed, most commonly as having major depression. That’s not a small error rate, and the consequences can be severe.

The problem starts with how bipolar disorder presents. Most people with bipolar disorder first seek help during a depressive episode, not during mania. You feel terrible, you can’t function, and you go to your doctor reporting classic depression symptoms. Sleep problems, no energy, can’t concentrate, thoughts of death.

Your doctor, especially if they’re a primary care physician without extensive psychiatric training, follows the diagnostic guidelines. You meet the criteria for major depression. They prescribe an antidepressant. And that’s where things can go very wrong.

Why the Diagnosis Gets Missed

Several factors contribute to this high misdiagnosis rate. First, patients often don’t recognize or report hypomanic symptoms. Hypomania can feel good. You’re productive, confident, don’t need much sleep, full of ideas. Why would you mention to your doctor that you had a period where you felt great?

From a psychodynamic perspective, there’s often an unconscious defense at work here. Patients may idealize hypomanic states as representing their “true self” while viewing depression as the illness. This splitting mechanism, where elevated moods are preserved as ego-syntonic (consistent with one’s self-image) and depressive states are rejected as ego-dystonic (foreign to the self), creates a powerful barrier to accurate diagnosis. The patient presents only the suffering they want relieved, not the full spectrum of mood states.

Second, the average time between symptom onset and accurate diagnosis is 7.5 to 10 years. During that time, you might see multiple providers, try numerous medications, and have your symptoms attributed to other causes.

Third, diagnostic interviews are often too brief. A comprehensive bipolar evaluation should include detailed questions about past mood episodes, family history, response to previous antidepressants, and subtle signs of hypomania that patients might not spontaneously report.

The Antidepressant Trap: When Treatment Triggers Mania

This is where misdiagnosis becomes genuinely dangerous. When someone with underlying bipolar disorder is treated with antidepressants alone, without mood stabilizers, they face a substantial risk of switching into mania or hypomania.

The research on this is both clear and concerning. Studies show that 20-40% of bipolar patients treated with antidepressants will experience a manic switch. One landmark study found that among bipolar patients initially misdiagnosed with unipolar depression, 55% developed mania after antidepressant treatment, and 23% became rapid cyclers.

What Antidepressant-Induced Mania Looks Like

You start an SSRI for depression. Within weeks, you feel better. Better than you’ve felt in years, actually. You’re sleeping only 4 hours a night and feeling great. Starting multiple projects, spending money, full of ideas. Your mood is elevated, but you attribute it to finally finding a medication that works.

Then things escalate. You can’t slow your thoughts down. You’re irritable with anyone who questions your decisions. Maybe you make impulsive choices that damage relationships or finances. You might not realize you’re manic until you crash back into depression, often worse than before.

The Rapid Cycling Risk

Perhaps even more concerning than single manic episodes is the risk of rapid cycling. Rapid cycling means having four or more mood episodes per year. Once established, it’s harder to treat and associated with worse outcomes.

Research by Wehr and colleagues found that in 51% of rapid cycling cases, antidepressant use was associated with the continuation of cycling. Seventy-three percent of rapid cyclers were taking antidepressants at the onset of their cycling pattern.

The Controversial Evidence

I need to mention that recent large-scale studies have challenged the traditional view of antidepressant-induced mania. A 2024 Danish nationwide study found no significant increase in mania risk when comparing bipolar patients treated with versus without antidepressants.

However, these newer studies have limitations. They often can’t distinguish between bipolar I and II, may miss acute switches within the first two weeks, and rely on hospitalization data rather than capturing milder hypomanic episodes.

The clinical reality is that many psychiatrists, myself included, have seen clear cases of antidepressant-induced mood destabilization. The safest approach remains using mood stabilizers as the foundation of treatment, with antidepressants added only when needed and with careful monitoring.

Mood Stabilizers 101: Understanding Your Options

Mood stabilizers are the foundation of bipolar disorder treatment. Unlike antidepressants, which target depression alone, mood stabilizers work to prevent both manic and depressive episodes, or at minimum reduce their severity and frequency.

The term “mood stabilizer” is actually imprecise. Different medications have different patterns of effectiveness. Some work better for mania, some for depression, some for both. Understanding these differences helps explain why your psychiatrist might choose one over another.

The Main Categories

Lithium is the oldest and most studied mood stabilizer, with over 50 years of research supporting its use. It’s particularly effective for classic bipolar I with euphoric mania. Lithium is also the only medication proven to reduce suicide risk in bipolar disorder.

Anticonvulsants like valproate (Depakote), lamotrigine (Lamictal), and carbamazepine were originally developed for seizures but also stabilize mood. They work through different mechanisms than lithium and have different side effect profiles.

Atypical antipsychotics including quetiapine (Seroquel), lurasidone (Latuda), and cariprazine (Vraylar) are increasingly used for both acute treatment and maintenance. They can work faster than traditional mood stabilizers but come with their own set of concerns, particularly metabolic side effects.

Choosing the Right Medication

Your psychiatrist considers several factors when selecting a mood stabilizer. The type of bipolar disorder matters. Bipolar I with prominent mania responds well to lithium. Bipolar II with more depression than hypomania might do better with lamotrigine.

Your specific symptoms matter. Mixed episodes (depression and mania at the same time) respond better to valproate or atypical antipsychotics than to lithium. Rapid cycling may need combination therapy.

Your medical history and tolerability matter. Kidney disease complicates lithium use. Liver disease affects valproate. History of rash makes lamotrigine riskier. Weight concerns might favor lamotrigine over olanzapine.

Lithium: The Gold Standard with a Catch

Lithium has been used for bipolar disorder since the 1970s, and despite newer alternatives, it remains the gold standard for several important reasons.

First, lithium is the most effective medication for preventing both manic and depressive episodes in the long term. Meta-analyses consistently show lithium outperforms other mood stabilizers for maintenance treatment in bipolar I disorder.

Second, lithium is the only psychiatric medication proven to reduce suicide risk. This isn’t a small benefit. Suicide risk in bipolar disorder is 20 times higher than the general population. Lithium reduces that risk by approximately 80%.

Third, lithium has unique neuroprotective effects. Research suggests it may protect against cognitive decline and has anti-inflammatory properties that extend beyond psychiatry.

The Downsides

So why doesn’t everyone with bipolar disorder take lithium? The side effects and monitoring requirements create real barriers.

Lithium has a narrow therapeutic window, meaning the difference between an effective dose and a toxic dose is small. This requires regular blood level monitoring, typically every few months once stabilized.

Common side effects include tremor (often manageable but bothersome), increased thirst and urination, weight gain (average 10-20 pounds), and cognitive effects that some describe as feeling slightly dulled or slowed.

Long-term risks include thyroid dysfunction (20-30% of patients develop hypothyroidism) and kidney problems. The kidney concerns deserve attention. Lithium can affect kidney function over years, though severe kidney disease is rare if blood levels are properly monitored.

Who Should Consider Lithium

Despite its drawbacks, lithium should be seriously considered for anyone with bipolar I disorder, particularly if you have classic episodic patterns with clear manias and depressions. If you have a family member who responded well to lithium, that predicts you may respond well too.

Lithium is especially important if you’ve had suicidal thoughts or attempts. No other medication has demonstrated the same suicide prevention benefit.

Lamotrigine: The Depression-Focused Alternative

Lamotrigine (brand name Lamictal) occupies a unique niche in bipolar treatment. While it’s not effective for acute mania, it excels at preventing depressive episodes, making it particularly valuable for bipolar II disorder where depression is more prominent than hypomania.

Why Lamotrigine Works Differently

Lamotrigine works by blocking voltage-sensitive sodium channels and reducing glutamate release in the brain. This mechanism differs from both lithium and other anticonvulsants, which partly explains its different effects.

Research shows lamotrigine significantly reduces the risk of depressive episode recurrence. In maintenance studies, it prevented depression at rates comparable to lithium but with better tolerability. However, it’s less effective than lithium at preventing manic episodes.

The Stevens-Johnson Concern

The main risk with lamotrigine is a rare but serious skin reaction called Stevens-Johnson syndrome. This occurs in approximately 1 in 3,000 patients, typically within the first few months of treatment.

The risk is substantially reduced by slow titration. Standard protocol starts at 25mg daily for two weeks, then gradually increases over 6 weeks to a maintenance dose of 200mg. You cannot speed this up safely.

If you develop any rash while taking lamotrigine, stop immediately and contact your psychiatrist. Most rashes aren’t Stevens-Johnson syndrome, but the risk is serious enough that any rash requires evaluation.

The Advantages

What makes lamotrigine attractive is its tolerability. Unlike lithium, it doesn’t require regular blood monitoring once you’re stable. Unlike many mood stabilizers and antipsychotics, it typically doesn’t cause weight gain.

Cognitive side effects are minimal for most patients. Many people report feeling clearer on lamotrigine compared to other mood stabilizers. Sexual side effects are rare.

The main downside, aside from the rash risk, is that lamotrigine works slowly. It can take 6-8 weeks just to reach therapeutic dose, and then several more weeks to see full benefit.

When One Medication Isn’t Enough: Combination Therapy

Many patients with bipolar disorder, perhaps even most, eventually need more than one medication. This isn’t treatment failure. It reflects the complexity of the disorder and the limitations of any single medication.

Common Combinations and Why They Work

Lithium plus lamotrigine is a particularly elegant combination. Lithium prevents mania and provides suicide protection. Lamotrigine prevents depression without triggering mania. Together, they cover both poles of the illness.

Research on this combination for rapid cycling shows promising results, though the evidence base is smaller than for monotherapy. Some patients achieve stability on this combination after years of failed single-drug trials.

Mood stabilizer plus antipsychotic is increasingly common, particularly for patients with mixed episodes or who don’t respond adequately to mood stabilizers alone. Quetiapine or lurasidone added to lithium or lamotrigine can target depressive symptoms that persist despite mood stabilization.

The Risks of Polypharmacy

More medications mean more side effects, more drug interactions, and more complexity in figuring out what’s helping versus what’s hurting. There’s also a real risk of “kitchen sink” prescribing where medications are added without clear rationale or proper trials of individual agents.

Good combination therapy has clear logic. Each medication serves a specific purpose. There’s a plan for monitoring effectiveness and a willingness to simplify if possible.

When to Consider Adding Rather Than Switching

If a medication is partially working but not fully effective, adding another medication often makes more sense than switching. For example, if lithium stabilizes your mania but depression breaks through, adding lamotrigine is more rational than stopping the lithium that’s helping.

If you have no response or intolerable side effects, switching makes more sense than piling on additional drugs.

What to Expect: The Medication Timeline

Understanding realistic timelines helps set appropriate expectations and prevents premature medication changes when drugs haven’t had adequate time to work.

Acute Phase: First 2-8 Weeks

If you’re starting treatment during a manic or depressive episode, some medications work faster than others. Atypical antipsychotics can reduce acute mania within days to weeks. Lithium takes 2-4 weeks for antimanic effects.

For depression, don’t expect rapid results from mood stabilizers. Lamotrigine can’t even reach therapeutic dose for 6 weeks. Lithium’s antidepressant effects emerge slowly over 4-6 weeks.

Stabilization Phase: 2-6 Months

Once acute symptoms improve, the goal shifts to achieving stable euthymia, normal mood without depression or mania. This takes time. Your brain needs to adjust to medication and reestablish more normal patterns.

During this phase, medication doses are often adjusted based on response and tolerability. Blood levels are checked if using lithium. Side effects may improve as your body adapts.

Maintenance Phase: Long Term

Bipolar disorder is a chronic condition. For most patients, maintenance medication is lifelong. The medications that got you stable should generally be continued to keep you stable.

This is where many patients run into trouble. You feel good, you’ve been stable for months, maybe a year. You wonder if you really need the medication anymore. You try stopping or reducing it. Then you have another episode.

Research shows that discontinuing mood stabilizers leads to relapse in most patients within one to two years. The longer you’ve been stable, the harder it is to regain that stability after stopping medication.

Written By

Cara J. Erkut, M.D.

Board-Certified Psychiatrist | Psychoanalyst | TMS Program Director

Dr. Erkut is a board-certified psychiatrist and psychoanalyst with expertise in mood disorders, complex medication management, and psychodynamic therapy. She provides comprehensive psychiatric care at her Mercer Island practice.